dc.contributor.author | Sandler, Carolina X | |
dc.contributor.author | Wyller, Vegard B. B | |
dc.contributor.author | Moss-Morris, Rona | |
dc.contributor.author | Buchwald, Dedra | |
dc.contributor.author | Crawley, Esther | |
dc.contributor.author | Hautvast, Jeannine | |
dc.contributor.author | Katz, Ben Z | |
dc.contributor.author | Knoop, Hans | |
dc.contributor.author | Little, Paul | |
dc.contributor.author | Taylor, Renee | |
dc.contributor.author | Wensaas, Knut-Arne | |
dc.contributor.author | Lloyd, Andrew R | |
dc.date.accessioned | 2022-03-21T13:09:26Z | |
dc.date.available | 2022-03-21T13:09:26Z | |
dc.date.created | 2021-12-02T12:59:57Z | |
dc.date.issued | 2021 | |
dc.identifier.citation | Open Forum Infectious Diseases. 2021, 8 (10), . | en_US |
dc.identifier.issn | 2328-8957 | |
dc.identifier.uri | https://hdl.handle.net/11250/2986519 | |
dc.description.abstract | Fatigue is a dominant feature of both acute and convalescent coronavirus disease 2019 (COVID-19) (sometimes termed “long-COVID”), with up to 46% of patients reporting fatigue that lasts from weeks to months. The investigators of the international Collaborative on Fatigue Following Infection (COFFI) conducted a systematic review of post-COVID fatigue and a narrative review on fatigue after other infections, and made recommendations for clinical and research approaches to assessing fatigue after COVID-19. In the majority of COVID-19 cohort studies, persistent fatigue was reported by a significant minority of patients, ranging from 13% to 33% at 16–20 weeks post-symptom onset. Data from the prospective cohort studies in COFFI and others indicate that fatigue is also a prevalent outcome from many acute systemic infections, notably infectious mononucleosis, with a case rate for clinically significant Post-infective fatigue after exclusion of recognized medical and psychiatric causes, ranging from 10%–35% at 6 months. To better characterize post-COVID fatigue, the COFFI investigators recommend the following: application of validated screening questionnaires for case detection; standardized interviews encompassing fatigue, mood, and other symptoms; and investigative approaches to identify end-organ damage and mental health conditions. | en_US |
dc.language.iso | eng | en_US |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/deed.no | * |
dc.title | Long COVID and post-infective fatigue syndrome: A review | en_US |
dc.type | Journal article | en_US |
dc.type | Peer reviewed | en_US |
dc.rights.holder | © The Author(s) 2021 | en_US |
dc.description.version | publishedVersion | en_US |
cristin.ispublished | true | |
cristin.fulltext | original | |
cristin.qualitycode | 1 | |
dc.identifier.doi | 10.1093/ofid/ofab440 | |
dc.identifier.cristin | 1963401 | |
dc.source.journal | Open Forum Infectious Diseases | en_US |
dc.source.volume | 8 | en_US |
dc.source.issue | 10 | en_US |
dc.source.pagenumber | 7 | en_US |